http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-974117-L
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e9445e5e3626f36e932c6451a928250 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-301 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-38 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-655 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-58 |
| filingDate | 1997-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c33651eefa29610fc8cc540961592533 |
| publicationDate | 1993-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NO-974117-L |
| titleOfInvention | Novel aminoalkane phosphinic acids and their salts |
| abstract | Compound of Formula I wherein R represents benzyl, R 4 represents hydroxy, R 2 represents α-cyclopropyl-3,4-dichloro-benzyl-trimethoxybenzyl, 1- (3,5-Dimethoxyphenyl) ethyl, 1- (3,4-dichlorophenyl) ethyl, 2- (3,4-dichlorophenyl) ethyl, 1- (3-chloro-4-iodo-phenyl) ethyl, 2- (3,4-dl chlorophenyl) -2-hydroxyethyl, 2- (3,4-dichlorophenyl) -2-hydroxyethyl, 1- (2,4-dimethoxyphenyl) ethyl, 1- (2,5 (1- (3,4-dimethoxyphenyl) ethyl) 1- (3,4-methylenedioxyphenyl) ethyl, 1- (3,4,5-trimethoxyphenyl) ethyl, 1- (3,4,5-methylmethoxyphenyl) ethyl ethyl, 3-phenylprop-2-yl, 3-phenyl-3-hydroxy-prop-2-yl, 1-, 2- or 3- (3,4-dichlorophenyl) propyl, 3- (3,4-dichlorophenyl) prop-2-yl, 3- (3,4-dichlorophenyl) -3-hydroxy-prop-2-yl or 4- (3,4-dichlorophenyl) butyl and R3 stands for hydrogen, or R stands for 4-chlorobenzyl, 4-methylbenzyl, 4-methoxybenzyl or cyclohex-3-enylmethyl and R 1, R 2 and R 3 represent hydrogen, and their salts have GABAg antagonist properties and can be used in the treatment of diseases affected of GABAg antagonists. |
| priorityDate | 1991-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.